Active

OphthaFund

Investor type

VC

Founded

2019

AUM

$30 M

Location

Charleston, South Carolina, United States

Investment Ticket

$10-50 m

Investment Stage

Seed Series A

Region of investment

North America
Investor profile last updated: 19 February, 2025

Profile

We are early stage investors focused on the future of ophthalmology & life sciences.

Working collaboratively with investors, OpthaFund selects the top companies in the industry in order to support and guide strategic investments. With a diversified investment portfolio, OphthaFund has already led numerous successful investments through funding rounds for innovators within the Ophthalmology industry.

Industry

Biotechnology Healthcare Services Medical Devices Pharmaceuticals MedTech Life Sciences HealthTech

OphthaFund Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
ForwardVue Pharma
Venture Capital (VC)
Biotechnology
Seed
Series A
North America
$5-10 m
$1 M
August 2020
Allysta Pharmaceuticals
Venture Capital (VC)
Biotechnology
Pharmaceuticals
Series A
North America
$5-10 m
$20 M
November 2022

Contacts

Name
Title
Email
avatar
George Magrath Co-Founder & Venture Principle
Co-Founder & Venture Principle
-
avatar
Tom Mather Co-Founder & Venture Principle
Co-Founder & Venture Principle
-
Upgrade to see contacts
avatar
LTp7mYW0zj8aG1gN LTp7mYW0zj8aG1gN
LTp7mYW0zj8aG1gN
avatar
LTp7mYW0zj8aG1gN LTp7mYW0zj8aG1gN
LTp7mYW0zj8aG1gN
avatar
LTp7mYW0zj8aG1gN LTp7mYW0zj8aG1gN
LTp7mYW0zj8aG1gN
Investment-team contacts for OphthaFund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about OphthaFund

OphthaFund is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $10-50 m.
OphthaFund is located in Charleston, South Carolina, United States.
OphthaFund was founded in 2019.
OphthaFund invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, HealthTech.
OphthaFund invests in companies and startups in North America.
OphthaFund invests in companies and startups at Seed, Series A.
OphthaFund usually invests $10-50 m on average.
OphthaFund has around $30m assets under management.
OphthaFund last fund was created/launched in 2022-11-08
OphthaFund can be reached through its website ophthafund.com, its LinkedIn page and its X account. Its general enquiries address is info@ophthafund.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for OphthaFund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query OphthaFund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 19 February, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.